What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Microalbuminuria is an important risk factor for cardiovascular disease and progressive renal impairment. This holds true in the general population and particularly in those with diabetes, in whom it is common and marks out those likely to develop macrovascular disease and progressive renal impairment. Understanding the pathophysiological mechanisms through which microalbuminuria occurs holds the key to designing therapies to arrest its development and prevent these later manifestations. Microalbuminuria arises from the increased passage of albumin through the glomerular filtration barrier. This requires ultrastructural changes rather than alterations in glomerular pressure or filtration rate alone. Compromise of selective glomerular permeability can be confirmed in early diabetic nephropathy but does not correlate well with reported glomerular structural changes. The loss of systemic endothelial glycocalyx--a protein-rich surface layer on the endothelium--in diabetes suggests that damage to this layer represents this missing link. The epidemiology of microalbuminuria reveals a close association with systemic endothelial dysfunction and with vascular disease, also implicating glomerular endothelial dysfunction in microalbuminuria. Our understanding of the metabolic and hormonal sequelae of hyperglycaemia is increasing, and we consider these in the context of damage to the glomerular filtration barrier. Reactive oxygen species, inflammatory cytokines and growth factors are key players in this respect. Taken together with the above observations and the presence of generalised endothelial dysfunction, these considerations lead to the conclusion that glomerular endothelial dysfunction, and in particular damage to its glycocalyx, represents the most likely initiating step in diabetic microalbuminuria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · cited 1×
“The relationship between microalbuminuria and vascular disease suggests a common causality, as established risk factors explain at most a small part of these associations [25].”
BackgroundAdler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Cell biology of the glomerular podocyte
Pavenstädt, H., Kriz, W., & Kretzler, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00020.2002 · Cited by 1,499 · cited 2×
“Podocyte biology has been reviewed in detail elsewhere [44].”
BackgroundAlbuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Diabetes, Hypertension, and Cardiovascular Disease: An Update
Sowers, J. R., Epstein, M., & Frohlich, E. D. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1053 · Cited by 1,332
Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,313
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304 · cited 1×
“Markers of chronic low-grade inflammation, including C-reactive protein (CRP), are also correlated with microalbuminuria in type 1 and type 2 diabetes [27], and increasing evidence from the non-diabetic population indicates the importance of inflammation in the pathogenesis of cardiovascular disease [28].”
BackgroundSusztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Podocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907 · cited 1×
“nitric oxide synthase (eNOS) activity by hyperglycaemia in endothelial cells [73].”
BackgroundZiyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
Schalkwijk, C. G., & Stehouwer, C. D. A. (2005) · Clinical Science · doi:10.1042/cs20050025 · Cited by 657
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652 · cited 1×
“While in some type 2 diabetic patients microalbuminuria may occur in the absence of evidence of endothelial dysfunction, in others, vWF levels predict its development [30].”
BackgroundHillege, H. L., Janssen, W. M. T., Bak, A. A. A., Diercks, G. F. H., Grobbee, D. E., Crijns, H. J. G. M., Van Gilst, W. H., De Zeeuw, D., De Jong, P. E., & FOR THE PREVEND STUDY GROUP (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00833.x · Cited by 629
Nieuwdorp, M., van Haeften, T. W., Gouverneur, M. C. L. G., Mooij, H. L., van Lieshout, M. H. P., Levi, M., Meijers, J. C. M., Holleman, F., Hoekstra, J. B. L., Vink, H., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1103 · Cited by 620
Vink, H., & Duling, B. R. (1996) · Circulation Research · doi:10.1161/01.res.79.3.581 · Cited by 615
Dinneen, S. F. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440340025002 · Cited by 574
Smith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Cooper, M. E., Vranes, D., Youssef, S., Stacker, S. A., Cox, A. J., Rizkalla, B., Casley, D. J., Bach, L. A., Kelly, D. J., & Gilbert, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2229 · Cited by 474
Familial factors determine the development of diabetic nephropathy in patients with IDDM
Quinn, M., Angelico, M. C., Warram, J. H., & Krolewski, A. S. (1996) · Diabetologia · doi:10.1007/bf00403913 · Cited by 464
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF
Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J., & Cao, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101564798 · Cited by 446 · cited 14×
“VEGF has the potential to induce the new vessel growth seen in early diabetic nephropathy [53] and to alter the permeability characteristics of the endothelium.”
BackgroundInfluentialEndothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes
Nieuwdorp, M., Mooij, H. L., Kroon, J., Atasever, B., Spaan, J. A. E., Ince, C., Holleman, F., Diamant, M., Heine, R. J., Hoekstra, J. B. L., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1619 · Cited by 442
DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Urinary Albumin Excretion: An Independent Predictor of Ischemic Heart Disease
Borch-Johnsen, K., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Jensen, J. S. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.1992 · Cited by 437
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
Rossing, P., Hougaard, P., Borch-Johnsen, K., & Parving, H.-H. (1996) · BMJ · doi:10.1136/bmj.313.7060.779 · Cited by 428
Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms
Stehouwer, C. D. A., & Smulders, Y. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121288 · Cited by 428
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Jensen, J. S., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Borch-Johnsen, K. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.898 · Cited by 425
Structural determinants of glomerular permeability
Deen, W. M., Lazzara, M. J., & Myers, B. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.4.f579 · Cited by 413
Biological applications of atomic force microscopy
Lal, R., & John, S. A. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.1.c1 · Cited by 402
Satoh, M., Fujimoto, S., Haruna, Y., Arakawa, S., Horike, H., Komai, N., Sasaki, T., Tsujioka, K., Makino, H., & Kashihara, N. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00221.2004 · Cited by 354
Schrijvers, B. F., De Vriese, A. S., & Flyvbjerg, A. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0018 · Cited by 353
TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx
Henry, C. B. S., & Duling, B. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.6.h2815 · Cited by 325
Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria
White, K. E., Bilous, R. W., Marshall, S. M., El Nahas, M., Remuzzi, G., Piras, G., De Cosmo, S., Viberti, G., & (ESPRIT), O. B. O. T. E. S. F. T. P. O. R. D. I. T. 1. D. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3083 · Cited by 315
Warram, J. H., Gearin, G., Laffel, L., & Krolewski, A. S. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v76930 · Cited by 313
Schalkwijk, C. G., Poland, D. C. W., van Dijk, W., Kok, A., Emeis, J. J., Dräger, A. M., Doni, A., van Hinsbergh, V. W. M., & Stehouwer, C. D. A. (1999) · Diabetologia · doi:10.1007/s001250051162 · Cited by 309
Flyvbjerg, A., Dagnæs-Hansen, F., De Vriese, A. S., Schrijvers, B. F., Tilton, R. G., & Rasch, R. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3090 · Cited by 309
Is Podocyte Injury Relevant in Diabetic Nephropathy?
Dalla Vestra, M., Masiero, A., Roiter, A. M., Saller, A., Crepaldi, G., & Fioretto, P. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1031 · Cited by 301
Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability
Singh, A., Satchell, S. C., Neal, C. R., McKenzie, E. A., Tooke, J. E., & Mathieson, P. W. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010119 · Cited by 300
Self-citationRehm, M., Zahler, S., Lötsch, M., Welsch, U., Conzen, P., Jacob, M., & Becker, B. F. (2004) · Anesthesiology · doi:10.1097/00000542-200405000-00025 · Cited by 276
Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
Saraheimo, M., Teppo, A.-M., Forsblom, C., Fagerudd, J., & Groop, P.-H. (2003) · Diabetologia · doi:10.1007/s00125-003-1194-5 · Cited by 255
Insulin resistance in insulin-dependent diabetic patients with microalbuminuria
Yip, J., Mattock, M. B., Morocutti, A., Sethi, M., Trevisan, R., & Viberti, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91943-g · Cited by 245
Jeansson, M., & Haraldsson, B. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00173.2005 · Cited by 231
Satchell, S. C., Tasman, C. H., Singh, A., Ni, L., Geelen, J., von Ruhland, C. J., O'Hare, M. J., Saleem, M. A., van den Heuvel, L. P., & Mathieson, P. W. (2006) · Kidney International · doi:10.1038/sj.ki.5000277 · Cited by 230
Self-citationRyan, G. B., & Karnovsky, M. J. (1976) · Kidney International · doi:10.1038/ki.1976.5 · Cited by 225
Endothelial Dysfunction Precedes Development of Microalbuminuria in IDDM
Stehouwer, C. D. A., Andreas Fischer, H. R., Van Kuijk, A. W. R., Polak, B. C. P., & Donker, A. J. M. (1995) · Diabetes · doi:10.2337/diab.44.5.561 · Cited by 222
Jensen, J. S., Borch-Johnsen, K., Jensen, G., & Feldt-Rasmussen, B. (1995) · Clinical Science · doi:10.1042/cs0880629 · Cited by 220
Stehouwer, C. D. A., Henry, R. M. A., Dekker, J. M., Nijpels, G., Heine, R. J., & Bouter, L. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09211.x · Cited by 211
Structural involvement in type 1 and type 2 diabetic nephropathy.
Vestra, M. D., Saller, A., Bortoloso, E., Mauer, M. S., & Fioretto, P. (2000) · PubMed · Cited by 194
Yang, X., & Smith, U. (2007) · Diabetologia · doi:10.1007/s00125-007-0640-1 · Cited by 194
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Chaturvedi, N., Bandinelli, S., Mangili, R., Penno, G., Rottiers, R. E., & Fuller, J. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00789.x · Cited by 191
Bianchi, S., Bigazzi, R., & Campese, V. M. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70002-8 · Cited by 188
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
Hohenstein, B., Hausknecht, B., Boehmer, K., Riess, R., Brekken, R. A., & Hugo, C. P. M. (2006) · Kidney International · doi:10.1038/sj.ki.5000294 · Cited by 182
van den berg, J. G., van den Bergh Weerman, M. A., Assmann, K. J. M., Weening, J. J., & Florquin, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00964.x · Cited by 180
Electron Microscopic Demonstrations of Filamentous Molecular Sieve Plugs in Capillary Fenestrae
Rostgaard, J., & Qvortrup, K. (1997) · Microvascular Research · doi:10.1006/mvre.1996.1987 · Cited by 178
Friedl, J., Puhlmann, M., Bartlett, D. L., Libutti, S. K., Turner, E. N., Gnant, M. F. X., & Alexander, H. R. (2002) · Blood · doi:10.1182/blood.v100.4.1334.h81602001334_1334_1339 · Cited by 177
Increased levels of acute-phase serum proteins in diabetes
McMillan, D. E. (1989) · Metabolism · doi:10.1016/0026-0495(89)90038-3 · Cited by 175
Why Do We Not All Have Proteinuria? An Update of Our Current Understanding of the Glomerular Barrier
Haraldsson, B. S., & Sörensson, J. (2004) · Physiology · doi:10.1152/nips.01461.2003 · Cited by 161
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
Kim, N. H., Oh, J. H., Seo, J. A., Lee, K. W., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Kang, Y. S., Han, S. Y., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00067.x · Cited by 147
A gel-membrane model of glomerular charge and size selectivity in series
Ohlson, M., Sörensson, J., & Haraldsson, B. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f396 · Cited by 145
Navarro‐González, J. F., Milena, F. F., Mora, C., León, C., Claveríe‐Martín, F., Flores, C. G., & García, J. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09918.x · Cited by 144
An analysis of the permeability of a fenestra
Levick, J. R., & Smaje, L. H. (1987) · Microvascular Research · doi:10.1016/0026-2862(87)90020-3 · Cited by 142
Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments
Huxley, V. H., & Williams, D. A. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1177 · Cited by 142
Chiarelli, F., Spagnoli, A., Basciani, F., Tumini, S., Mezzetti, A., Cipollone, F., Cuccurullo, F., Morgese, G., & Verrotti, A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00350.x · Cited by 133
Oral Contraceptive Use and Hormone Replacement Therapy Are Associated With Microalbuminuria
Monster, T. B. M., Janssen, W. M., de Jong, P. E., & den Berg, L. T. D. J.-V. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.2000 · Cited by 130
Attenuation of Renal Injury in db/db Mice Overexpressing Superoxide Dismutase
DeRubertis, F. R., Craven, P. A., Melhem, M. F., & Salah, E. M. (2004) · Diabetes · doi:10.2337/diabetes.53.3.762 · Cited by 129
Deckert, T., Kofoed‐Enevoldsen, A., Vidal, P., N�rgaard, K., Andreasen, H. B., & Feldt‐Rasmussen, B. (1993) · Diabetologia · doi:10.1007/bf00399958 · Cited by 127
Fioretto, P., Stehouwer, C. D. A., Mauer, M. S., Chiesura-Corona, M., Brocco, E., Carraro, A., Bortoloso, E., van Hinsbergh, V. W. M., Crepaldi, G., & Nosadini, R. (1998) · Diabetologia · doi:10.1007/s001250050895 · Cited by 126
Series of Monographs on Venous Thromboembolic Disease
Jaff, M. R., & Halperin, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000122867.89751.59 · Cited by 126
Wang, A., Ziyadeh, F. N., Lee, E. Y., Pyagay, P. E., Sung, S. H., Sheardown, S. A., Laping, N. J., & Chen, S. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00274.2007 · Cited by 121
Diabetic Nephropathy: The Proteinuria Hypothesis
Williams, M. E. (2005) · American Journal of Nephrology · doi:10.1159/000084286 · Cited by 117
Hovind, P. H., Rossing, P. R., Tarnow, L., Smidt, U., & Parving, H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00797.x · Cited by 115
Ohlson, M., Sörensson, J., Lindström, K., Blom, A. M., Fries, E., & Haraldsson, B. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.1.f103 · Cited by 97
Does Microalbuminuria Predict Diabetic Nephropathy?
Parving, H.-H., Chaturvedi, N., Viberti, G. C., & Mogensen, C. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.406 · Cited by 90
Glomerular Permselectivity at the Onset of Nephropathy in Type 2 Diabetes Mellitus
Lemley, K. V., Blouch, K. L., Abdullah, I., Boothroyd, D. B., Bennett, P. H., Myers, B. D., & Nelson, R. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11112095 · Cited by 90
Contribution of the Endothelium to the Glomerular Permselectivity Barrier in Health and Disease
Ballermann, B. J. (2007) · Nephron Physiology · doi:10.1159/000101796 · Cited by 88
Yoshioka, T., Ichikawa, I., & Fogo, A. B. (1991) · Journal of the American Society of Nephrology · doi:10.1681/asn.v24902 · Cited by 87
Model of albumin reabsorption in the proximal tubule
Lazzara, M. J., & Deen, W. M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00010.2006 · Cited by 87
Kashihara, N., Watanabe, Y., Makino, H., Wallner, E. I., & Kanwar, Y. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6309 · Cited by 74
Matsuda, M., Kawasaki, F., Yamada, K., Kanda, Y., Saito, M., Eto, M., Matsuki, M., & Kaku, K. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01261.x · Cited by 67
Therapeutic Potential of Angiostatin in Diabetic Nephropathy
Zhang, S. X., Wang, J. J., Lu, K., Mott, R., Longeras, R., & Ma, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020217 · Cited by 65
Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease.
Mahmud, N. U., O'Connell, M. A., Stinson, J. C., Goggins, M., Weir, D. G., & Kelleher, D. P. (1995) · PubMed · Cited by 48
Epidemiology of microalbuminuria in diabetes and in the background population
Mogensen, C. E., & Poulsen, P. L. (1994) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199405000-00004 · Cited by 45
Jensen, J. S., Borch‐Johnsen, K., Deckert, T., Deckert, M., Jensen, G. B., & Feldt‐Rasmussen, B. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01753.x · Cited by 36
Grønbæk, H., Vogel, I., Østerby, R., Lancranjan, I., Flyvbjerg, A., & Ørskov, H. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00720.x · Cited by 33
Superoxide Dismutase Mimetic Preserves the Glomerular Capillary Permeability Barrier to Protein
Duann, P., Datta, P. K., Pan, C. G., Blumberg, J. B., Sharma, M., & Lianos, E. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092957 · Cited by 31
Factors associated with microalbuminuria in Type 1 diabetes mellitus: a cross-sectional study
Campos-Pastor, M. M., Escobar‐Jiménez, F., Mezquita, P., Herrera-Pombo, J. L., Hawkins-Carranza, F., Luna, J. D. D., Azriel, S., Serraclara, A., & Rigopoulos, M. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00133-3 · Cited by 19
Cited by
National Health and Nutrition Examination Survey
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6177 · Cited by 2,087
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Martín-Timón, I. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 976
Diabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660
“Possessing a crucial role in maintaining normal glomerular capillary permeability, endothelial cells and podocytes become structurally immature with diminution of the endothelial glycocalyx in hyperglycemic conditions (224).”
Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk
Grundy, S. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.080 · Cited by 627
Metadata
- Authors
- Satchell, S. C., & Tooke, J. E.
- Venue
- Diabetologia
- Published
- 2008-03-18
- Volume
- 51
- Issue
- 5
- Pages
- 714-725
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2061145694
- Cited by
- 361
- References
- 88
- FWCI
- 17.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.